Acorah Software Products - Accounts Production 16.7.461 false true 31 March 2024 1 April 2023 false 1 April 2024 31 March 2025 31 March 2025 SC209236 Dr Robert Swingler Dr Kate El-Bouzidi iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure SC209236 2024-03-31 SC209236 2025-03-31 SC209236 2024-04-01 2025-03-31 SC209236 frs-core:PlantMachinery 2024-04-01 2025-03-31 SC209236 frs-core:ShareCapital 2025-03-31 SC209236 frs-core:RetainedEarningsAccumulatedLosses 2025-03-31 SC209236 frs-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 SC209236 frs-bus:AbridgedAccounts 2024-04-01 2025-03-31 SC209236 frs-bus:SmallEntities 2024-04-01 2025-03-31 SC209236 frs-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 SC209236 frs-bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 SC209236 frs-bus:Director1 2024-04-01 2025-03-31 SC209236 frs-bus:Director2 2024-04-01 2025-03-31 SC209236 frs-countries:Scotland 2024-04-01 2025-03-31 SC209236 2023-03-31 SC209236 2024-03-31 SC209236 2023-04-01 2024-03-31 SC209236 frs-core:ShareCapital 2024-03-31 SC209236 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31
Registered number: SC209236
Neurology Partnership Limited
ABRIDGED Financial Statements
For The Year Ended 31 March 2025
James Fraser & Co.
Chartered Accountants
15 Manor Place
Edinburgh
EH3 7DH
Contents
Page
Abridged Balance Sheet 1—2
Notes to the Abridged Financial Statements 3
Page 1
Abridged Balance Sheet
Registered number: SC209236
2025 2024
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 3,127 3,430
3,127 3,430
CURRENT ASSETS
Debtors 13,109 -
Cash at bank and in hand 26,907 45,200
40,016 45,200
Creditors: Amounts Falling Due Within One Year (390 ) (1,773 )
NET CURRENT ASSETS (LIABILITIES) 39,626 43,427
TOTAL ASSETS LESS CURRENT LIABILITIES 42,753 46,857
NET ASSETS 42,753 46,857
CAPITAL AND RESERVES
Called up share capital 5 140 140
Profit and Loss Account 42,613 46,717
SHAREHOLDERS' FUNDS 42,753 46,857
Page 1
Page 2
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
All of the company's members have consented to the preparation of an Abridged Balance Sheet for the year end 31 March 2025 in accordance with section 444(2A) of the Companies Act 2006.
On behalf of the board
Dr Robert Swingler
Director
9 December 2025
The notes on page 3 form part of these financial statements.
Page 2
Page 3
Notes to the Abridged Financial Statements
1. General Information
Neurology Partnership Limited is a private company, limited by shares, incorporated in Scotland, registered number SC209236 . The registered office is 15 Manor Place, Edinburgh, EH3 7DH.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Plant & Machinery 25% reducing balance
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2024: 2)
2 2
4. Tangible Assets
Total
£
Cost
As at 1 April 2024 22,270
As at 31 March 2025 22,270
Depreciation
As at 1 April 2024 18,840
Provided during the period 303
As at 31 March 2025 19,143
Net Book Value
As at 31 March 2025 3,127
As at 1 April 2024 3,430
5. Share Capital
2025 2024
£ £
Allotted, Called up and fully paid 140 140
Page 3